The 4 most recent market catalysts affecting $CNTX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 85
Context Therapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS results.
This headline represents a direct corporate catalyst impacting Context Therapeutics. Worse-than-expected EPS results often lead to immediate negative sentiment and a sell-off in th…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 95
Context Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move
Context Therapeutics (CNTX) experienced a significant after-hours drop following its Q2 2026 earnings report. The company's net loss widened substantially from $8.8 million to $14.…
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 92
Context Therapeutics Q2 EPS $(0.15) Misses $(0.09) Estimate
Context Therapeutics (CNTX) announced Q2 earnings that significantly missed analyst expectations, reporting a loss of $(0.15) per share compared to an estimated $(0.09). This 66.67…
Jul 31, 2026
Corporate Catalyst
Neutral
Impact 75
Context Therapeutics Receives Nasdaq Noncompliance Notice, Gets Time Through Jan. 25 To Regain Compliance
Context Therapeutics (CNTX) has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement, as its stock traded below $1.00 for 30 consecutive busi…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.